2025-04-012026-03-312026-03-31false15831989RUSKIN CLINIC LTD2026-09-10falseiso4217:GBPxbrli:pure158319892025-03-31158319892026-03-31158319892025-04-012026-03-31158319892024-07-09158319892025-03-31158319892024-07-102025-03-3115831989bus:SmallEntities2025-04-012026-03-3115831989bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3115831989bus:FullAccounts2025-04-012026-03-3115831989bus:PrivateLimitedCompanyLtd2025-04-012026-03-3115831989core:WithinOneYear2026-03-3115831989core:AfterOneYear2026-03-3115831989core:WithinOneYear2025-03-3115831989core:AfterOneYear2025-03-3115831989core:ShareCapital2026-03-3115831989core:SharePremium2026-03-3115831989core:RevaluationReserve2026-03-3115831989core:OtherReservesSubtotal2026-03-3115831989core:RetainedEarningsAccumulatedLosses2026-03-3115831989core:ShareCapital2025-03-3115831989core:SharePremium2025-03-3115831989core:RevaluationReserve2025-03-3115831989core:OtherReservesSubtotal2025-03-3115831989core:RetainedEarningsAccumulatedLosses2025-03-3115831989core:LandBuildings2026-03-3115831989core:PlantMachinery2026-03-3115831989core:Vehicles2026-03-3115831989core:FurnitureFittings2026-03-3115831989core:OfficeEquipment2026-03-3115831989core:NetGoodwill2026-03-3115831989core:IntangibleAssetsOtherThanGoodwill2026-03-3115831989core:ListedExchangeTraded2026-03-3115831989core:UnlistedNon-exchangeTraded2026-03-3115831989core:LandBuildings2025-03-3115831989core:PlantMachinery2025-03-3115831989core:Vehicles2025-03-3115831989core:FurnitureFittings2025-03-3115831989core:OfficeEquipment2025-03-3115831989core:NetGoodwill2025-03-3115831989core:IntangibleAssetsOtherThanGoodwill2025-03-3115831989core:ListedExchangeTraded2025-03-3115831989core:UnlistedNon-exchangeTraded2025-03-3115831989core:LandBuildings2025-04-012026-03-3115831989core:PlantMachinery2025-04-012026-03-3115831989core:Vehicles2025-04-012026-03-3115831989core:FurnitureFittings2025-04-012026-03-3115831989core:OfficeEquipment2025-04-012026-03-3115831989core:NetGoodwill2025-04-012026-03-3115831989core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3115831989core:ListedExchangeTraded2025-04-012026-03-3115831989core:UnlistedNon-exchangeTraded2025-04-012026-03-3115831989core:MoreThanFiveYears2025-04-012026-03-3115831989core:Non-currentFinancialInstruments2026-03-3115831989core:Non-currentFinancialInstruments2025-03-3115831989dpl:CostSales2025-04-012026-03-3115831989dpl:DistributionCosts2025-04-012026-03-3115831989core:LandBuildings2025-04-012026-03-3115831989core:PlantMachinery2025-04-012026-03-3115831989core:Vehicles2025-04-012026-03-3115831989core:FurnitureFittings2025-04-012026-03-3115831989core:OfficeEquipment2025-04-012026-03-3115831989dpl:AdministrativeExpenses2025-04-012026-03-3115831989core:NetGoodwill2025-04-012026-03-3115831989core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3115831989dpl:GroupUndertakings2025-04-012026-03-3115831989dpl:ParticipatingInterests2025-04-012026-03-3115831989dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3115831989core:ListedExchangeTraded2025-04-012026-03-3115831989dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3115831989core:UnlistedNon-exchangeTraded2025-04-012026-03-3115831989dpl:CostSales2024-07-102025-03-3115831989dpl:DistributionCosts2024-07-102025-03-3115831989core:LandBuildings2024-07-102025-03-3115831989core:PlantMachinery2024-07-102025-03-3115831989core:Vehicles2024-07-102025-03-3115831989core:FurnitureFittings2024-07-102025-03-3115831989core:OfficeEquipment2024-07-102025-03-3115831989dpl:AdministrativeExpenses2024-07-102025-03-3115831989core:NetGoodwill2024-07-102025-03-3115831989core:IntangibleAssetsOtherThanGoodwill2024-07-102025-03-3115831989dpl:GroupUndertakings2024-07-102025-03-3115831989dpl:ParticipatingInterests2024-07-102025-03-3115831989dpl:GroupUndertakingscore:ListedExchangeTraded2024-07-102025-03-3115831989core:ListedExchangeTraded2024-07-102025-03-3115831989dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-07-102025-03-3115831989core:UnlistedNon-exchangeTraded2024-07-102025-03-3115831989core:NetGoodwill2026-03-3115831989core:IntangibleAssetsOtherThanGoodwill2026-03-3115831989core:LandBuildings2026-03-3115831989core:PlantMachinery2026-03-3115831989core:Vehicles2026-03-3115831989core:FurnitureFittings2026-03-3115831989core:OfficeEquipment2026-03-3115831989core:AfterOneYear2026-03-3115831989core:WithinOneYear2026-03-3115831989core:ListedExchangeTraded2026-03-3115831989core:UnlistedNon-exchangeTraded2026-03-3115831989core:ShareCapital2026-03-3115831989core:SharePremium2026-03-3115831989core:RevaluationReserve2026-03-3115831989core:OtherReservesSubtotal2026-03-3115831989core:RetainedEarningsAccumulatedLosses2026-03-3115831989core:NetGoodwill2025-03-3115831989core:IntangibleAssetsOtherThanGoodwill2025-03-3115831989core:LandBuildings2025-03-3115831989core:PlantMachinery2025-03-3115831989core:Vehicles2025-03-3115831989core:FurnitureFittings2025-03-3115831989core:OfficeEquipment2025-03-3115831989core:AfterOneYear2025-03-3115831989core:WithinOneYear2025-03-3115831989core:ListedExchangeTraded2025-03-3115831989core:UnlistedNon-exchangeTraded2025-03-3115831989core:ShareCapital2025-03-3115831989core:SharePremium2025-03-3115831989core:RevaluationReserve2025-03-3115831989core:OtherReservesSubtotal2025-03-3115831989core:RetainedEarningsAccumulatedLosses2025-03-3115831989core:NetGoodwill2024-07-0915831989core:IntangibleAssetsOtherThanGoodwill2024-07-0915831989core:LandBuildings2024-07-0915831989core:PlantMachinery2024-07-0915831989core:Vehicles2024-07-0915831989core:FurnitureFittings2024-07-0915831989core:OfficeEquipment2024-07-0915831989core:AfterOneYear2024-07-0915831989core:WithinOneYear2024-07-0915831989core:ListedExchangeTraded2024-07-0915831989core:UnlistedNon-exchangeTraded2024-07-0915831989core:ShareCapital2024-07-0915831989core:SharePremium2024-07-0915831989core:RevaluationReserve2024-07-0915831989core:OtherReservesSubtotal2024-07-0915831989core:RetainedEarningsAccumulatedLosses2024-07-0915831989core:AfterOneYear2025-04-012026-03-3115831989core:WithinOneYear2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3115831989core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3115831989core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3115831989core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115831989core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115831989core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115831989bus:Director12025-04-012026-03-3115831989bus:Director22025-04-012026-03-31

RUSKIN CLINIC LTD

Registered Number
15831989
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

RUSKIN CLINIC LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

EYRUMLU, Azad, Dr
SHAKIR, Honar

Registered Address

74 Pentland Road
Slough
SL2 1TN

Registered Number

15831989 (England and Wales)
RUSKIN CLINIC LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets3392,950-
392,950-
Current assets
Debtors194,3821
Cash at bank and on hand118,863-
313,2451
Creditors amounts falling due within one year4(98,895)-
Net current assets (liabilities)214,3501
Total assets less current liabilities607,3001
Creditors amounts falling due after one year5(314,363)-
Net assets292,9371
Capital and reserves
Called up share capital11
Profit and loss account292,936-
Shareholders' funds292,9371
The financial statements were approved and authorised for issue by the Board of Directors on 10 September 2026, and are signed on its behalf by:
EYRUMLU, Azad, Dr
Director
SHAKIR, Honar
Director

Registered Company No. 15831989
RUSKIN CLINIC LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery7
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20262025
Average number of employees during the year02
3.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
Additions424,719424,719
At 31 March 26424,719424,719
Depreciation and impairment
Charge for year31,76931,769
At 31 March 2631,76931,769
Net book value
At 31 March 26392,950392,950
At 31 March 25--
4.Creditors: amounts due within one year

2026

2025

££
Bank borrowings and overdrafts49,937-
Finance lease and HP contracts35,007-
Other creditors13,202-
Accrued liabilities and deferred income749-
Total98,895-
5.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts184,755-
Other creditors129,608-
Total314,363-
6.Obligations under finance leases

2026

2025

££
Finance lease and HP contracts164,614-
7.Related party transactions
The intercompany balances consist entirely of related party transactions, which form part of the ultimate controlling party. The accumulated balance as at year end, owed by the company is £66,943.
8.Controlling party
The ultimate controlling party is Silicate Ltd.